The Effects of L-arginine Supplementation on Anaerobic Exercise Performance
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-39
SponsorUniversity of Manitoba
About this trial
The purpose of this study is to evaluate if acute ingestion of L-arginine will enhance anaerobic exercise performance in young, healthy, and recreationally active adults.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Recreationally physically active individuals will be recruited for the study. In this context it means all participants perform 1-hour of exercise per day over 3-days per week at a minimum for 1-month. All participants will be between the ages of 18-39 years of age.
Disqualifiers
Exclusion criteria for the study includes: 1) smokers; 2) unhealthy (have cardiovascular, metabolic, neurological, or psychological disease); 3) taking medication for any condition; 4) any known allergy to the supplements of interest (L-arginine or placebo [dextrose]).
Trial design
Design model
Crossover
Treatments tested in this trial
L-arginine
Dietary supplement2 grams iof L-arginine will be ingested before an acute testing bout of exercise tasks in 250 mL of cranberry juice.
Placebo
Dietary supplementPlacebo
Treatment groups
20 Participants
are divided into 2 treatment groupsGroup A: L-arginineExperimental treatment 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
Grip Strength
Grip strength measurement in kilograms of force produced on a hand held dynamometer.
Time frame
5 minutes2
Counter movement vertical jump
Counter movement vertical jump performance height in centimeters.
Time frame
3 minutes3
Wingate anaerobic cycle ergometer test
Maximum pedaling power output for 30 seconds of all-out sprinting on a cycle ergometer.
Time frame
30 secondsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov